{
  "articles": [
    {
      "path": "hollie.html",
      "title": "Hollie",
      "description": "For exploration\n",
      "author": [
        {
          "name": "Hollie and Charles",
          "url": {}
        }
      ],
      "date": "updated `r Sys.Date()`",
      "contents": "\n\nContents\nStuff for Hollie to investigate\nscales\nunmatched scales\nhigher direction of improvement\n\n\nHollie writes here:\nTutorial stuff from Charles\ntargets\nsyncing with Charles\n\nscales\ninvestigate unmatched scales\nnotes\nassumptions about scales\nchanges to make outcome extractions\nscales to discuss further/investigate\n\nusing gt::\n\n\n\n# if it says package not installed:\n# run renv::restore() in the console to install all packages\n\nlibrary(tidyverse) # vis and wrangling\nlibrary(targets) # pipeline\nlibrary(gt) # tables\n\nsource(\"R/hpp_themes.R\")\n\n\n\nStuff for Hollie to investigate\nscales\nunmatched scales\n\n\n# these are the scales that aren't matching yet\n# some have 0 matches some have > 1\n# hit the green play button in the right of this chunk to see all\n# aka_det matches aka column (not raw), cat_det matches scale_category column\n\nexcluded_scales <- \n  tar_read(w_obs_scale_excluded) %>%\nselect(study, arm, covidence_desc, scale_match) %>% \n  unnest(scale_match) \n\n# view it in RStudio\nexcluded_scales %>% \n  View()\n\n# if you want to export it as a csv, remove the # from the line below and run it\n# it will write to exports\n# write_csv(excluded_scales, \"export/excluded_scales.csv\")\n\n\n\nhigher direction of improvement\nFor direction of improvement higher find as many upper_range as possible, otherwise these observations will be excluded\n\n\n# just look at direction of improvement is higher in scales\n# AND that upper range check is FALSE\ntar_read(w_scales) %>% \n  mutate(upper_range_check = map(upper_range, is.double)) %>%\n  filter(direction_of_improvement != \"Lower\") %>%\n  select(direction_of_improvement, upper_range, upper_range_check, everything()) %>% \n  arrange(direction_of_improvement, upper_range_check) %>% \n  View()\n\n\n\nHollie writes here:\nThis is a test\nTutorial stuff from Charles\nNB: only edit this file\ntargets\nThe pipeline is managed by the targets:: package.\nA few key commmands.\nNB: we’ve turned off this “code chunk” because it takes ages to render\nYou can run single lines of code by hitting cmd + enter or the whole chunk by clicking the green play button.\n\n\n# inspect the pipeline\n\ntar_glimpse()\n\n# inspect a subset of the pipeline\n\n# run specific parts of the pipeline: starts_with *_\n\n# starts_with labels\n\n# r := raw\n# w := wrangling\n# m := model\n# c := check, for exporting checks and asserts\n# e := exploratory data analysis table or vis\n# p := pipeline design\n\n# secondary signifiers ^_*_\n\n# h := prepared by hollie\n\n# targets that contain\ntar_glimpse(allow = contains(\"_h_\"))\n\n# targets that start with\ntar_glimpse(allow = starts_with(\"r_\"))\n\n\n\nAccessing data from targets.\nDesired table output of all observations.\noutcome\nstudy\narm\nobservations\nobservation info\nstudy-level descriptors\noutcome label\nunique identifier for study\nunique identifier for arm\nmean, sd, counts, etc.\ntimepoint, scale, etc.\ncondition, study design (parallel/crossover), antyhing we need to filter by, subgroups, etc.\n\n\n# inspect the data at a point in the pipeline with \n\n# this is the output table described as the desired output at the top\n# of the pipeline (copied in above)\ntar_read(w_obs)\n\n\n\nsyncing with Charles\nNB: Charles is learning, too!\nSee this page for more details:\n\n\n# grab latest changes from Charles\npr_merge_main()\n\n# make changes\n# commit in the git pane\n\n# send changes to Charles\npr_push()\n\n\n\nscales\n\n\ntar_visnetwork(allow = c(contains(\"scale\"), w_obs_long))\n\ntar_read(w_obs_scale_counts)\n\ntar_read(w_obs_scale_snapshot)\n\n\n\ninvestigate unmatched scales\n\n\n# look at the first 0 matches\ntar_read(w_obs_scale_counts) %>% \n  filter(cat_n == 0,\n         # fix in Covidence bansal 2009 add in 0-4 \n         study != \"bansal 2009\",\n         # change kayiran vas 0-10 \n         study != \"kayiran 2010\",\n         # change extractions\n         !str_detect(covidence_desc, \"catastrophising\") \n         )\n\n\n\nnotes\nonly need range of scale if direction is higher not lower\nassumptions about scales\nkayiran 2010 lowest is ~1 and highest ~9, so we assumed it is 0-10 vas scale\nchanges to make outcome extractions\n\nexclude tetreault 2018 catatrosphising columns\nscales to discuss further/investigate\nchest_pain_pain_index_duration_of_chest_pain_weighed_by_the_intensity_of_chest_pain_baseline in spinhoven 2010\ntetreault 2018 - detect questionnaire scales\nusing gt::\ngt:: is an R package for creating tables\ncookbook\npkg site\n\n\n# example of using gt\n\ntar_read(w_obs) %>%\n  # select first 10 columns\n  select(1:5) %>% \n  select(-covidence) %>% \n  # first 10 rows\n  head(3) %>% \n  gt() %>% \n  hpp_tab(vertical_divider = \"outcome\")\n\n\n\n\n\n\n",
      "last_modified": "2021-08-05T11:26:40+01:00"
    },
    {
      "path": "index.html",
      "title": "Antidepressants for pain management in adults with chronic pain",
      "description": "A network meta-analysis\n",
      "author": [],
      "contents": "\n`\n\n\n\n",
      "last_modified": "2021-07-19T20:37:03+01:00"
    },
    {
      "path": "neuropathic.html",
      "title": "Neuropathic pain",
      "description": "Comparison and analysis of the treatment of fibromyalgia with antidepressants\n",
      "author": [],
      "date": "updated: `r Sys.Date()`",
      "contents": "\n\nContents\npackages\nreplication of amitriptyline and fibromyalgia\nnotes\nThree tiers of evidence\n\nOutcomes\nModel notes\nResults\nimport data from revman format\nthird-tier efficacy\n\nreproduction of amitriptyline and fibromyalgia\nreproduction of third-tier analysis\nreproduction with all studies\n\nextension\nnma of fibromyalgia\npain nma\n\n\n\n\nCurrent draft for discussion with Tamar, Gav, and Hollie. Will cut down for presentation to whole group.\n\npackages\n\n\nShow code\n\nlibrary(meta)\nlibrary(gt)\nlibrary(tidyverse)\nlibrary(skimr)\nlibrary(metafor)\nlibrary(targets)\nlibrary(multinma)\n\nsource(\"R/hpp_themes.R\")\n\n\n\nreplication of amitriptyline and fibromyalgia\nIn this section I replicate the substantial pain reduction findings of Moore et al. (Moore et al. 2015).\nnotes\nObjective: measure efficacy of analgesic efficacy and adverse events of amitriptyline on pain in fibromyalgia patients.\nThree tiers of evidence\n\nPossibly should incorporate these as variables into our analysis.\n\nFirst tier\nStudy design follows current best standards\nMinimal risk of bias\nOutcome equivalent to substantial pain reduction\nIntention to treat without inputation for dropouts (not sure what this means)\n\\(\\geqslant\\) 200 participants in comparison; i.e., total sample size across arms\n8-12 weeks duration\nparallel design\nSecond tier\nFailed to meet 1 or more items in First tier\nAt risk of bias\nThird tier\nOnly third-tier studies were found in the review\nSmall number of participants\nLikely to be biased\nOutcomes of limited clinical utility\nOutcomes\nAnalgesic efficacy: NNT (number needed to treat)\nHarm: NNH number heeded to treat to harm\n\nThis is only important for transformation in the summary of findings, that is, after the model’s log risk ratios have been calculated. Not important for model. Importantly, to calculate NNT and NNH, we require a something somehting.\n\nModel notes\nRisk ratio of 50% pain relief using a fixed-effect meta-analysis\nResults\n9 studies, 2 with cross-over design\n649 participants\n6-12 weeks duration\n25mg and 50mg dosages\nimport data from revman format\n\n\nShow code\n\nfib_ami_dat_raw <- read.rm5(\"data/fibromyalgia-amitriptyline.rm5\") %>% \n    janitor::clean_names() \n\n# tidy it up a bit\nfib_ami_dat <-\n  fib_ami_dat_raw %>% \n  rename(study = studlab, outcome =  outclab) %>% \n  select(study, event_c, event_e, n_c, n_e, outcome)   \n\n\n\nthird-tier efficacy\nOur objective is to replicate the results shown in this analysis.\n\n\nShow code\n\nknitr::include_graphics(\"external-figs/moore-third-tier.png\")\n\n\n\n\n\n\nShow code\n\nthird_tier_dat <- \n  fib_ami_dat %>% \n  filter(str_detect(outcome, \"Third-tier efficacy\"))\n  \nthird_tier_dat %>% \n  gt(groupname_col = \"outcome\") %>% \n  hpp_tab(vertical_divider = \"study\") %>% \n  tab_header(\"Studies included in third-tier efficacy analysis\")\n\n\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#kzeevnpcwc .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#kzeevnpcwc .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#kzeevnpcwc .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_col_heading {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#kzeevnpcwc .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#kzeevnpcwc .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#kzeevnpcwc .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#kzeevnpcwc .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#kzeevnpcwc .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#kzeevnpcwc .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#kzeevnpcwc .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#kzeevnpcwc .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#kzeevnpcwc .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#kzeevnpcwc .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#kzeevnpcwc .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#kzeevnpcwc .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#kzeevnpcwc .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#kzeevnpcwc .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#kzeevnpcwc .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#kzeevnpcwc .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#kzeevnpcwc .gt_left {\n  text-align: left;\n}\n\n#kzeevnpcwc .gt_center {\n  text-align: center;\n}\n\n#kzeevnpcwc .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#kzeevnpcwc .gt_font_normal {\n  font-weight: normal;\n}\n\n#kzeevnpcwc .gt_font_bold {\n  font-weight: bold;\n}\n\n#kzeevnpcwc .gt_font_italic {\n  font-style: italic;\n}\n\n#kzeevnpcwc .gt_super {\n  font-size: 65%;\n}\n\n#kzeevnpcwc .gt_footnote_marks {\n  font-style: italic;\n  font-weight: normal;\n  font-size: 65%;\n}\nStudies included in third-tier efficacy analysis\n    study\n      event_c\n      event_e\n      n_c\n      n_e\n    1.1 Third-tier efficacy\n    Carette 1986\n5\n6\n32\n27Carette 1994\n8\n30\n42\n84Carette 1995\n0\n6\n22\n22Ginsberg 1996\n0\n14\n22\n24\n\n\n\nShow code\n\nthird_tier_escalc <-\n  third_tier_dat %>%\n  # does adding the complement help?\n  mutate(comp_c = n_c - event_c, comp_e = n_e - event_e) %>%\n  escalc(\n    measure = \"RR\",\n    ai = event_e,\n    bi = comp_e,\n    n1i = n_e,\n    ci = event_c,\n    di = comp_c,\n    n2i = n_c,\n    dat = .\n  ) \n  \nthird_tier_rma <-   \n  rma(\n    yi = yi,\n    vi = vi,\n    slab = study,\n    data = third_tier_escalc\n  )\n\n\n\nthird_tier_mh <- \n  rma.mh(\n    slab = study,\n        measure = \"RR\",\n    ai = event_e,\n    bi = comp_e,\n    n1i = n_e,\n    ci = event_c,\n    di = comp_c,\n    n2i = n_c,\n    data = third_tier_dat %>%   \n      mutate(comp_c = n_c - event_c, comp_e = n_e - event_e),\n    add = 1/2\n\n\n  )  \n\n\nforest(third_tier_mh, transf = exp)\n\n\n\n\nOf course, Gav and I would likely do a random-effects model for this analysis, the results of which will likely adhere better to the NMA.\n\n\nShow code\n\nforest(third_tier_rma, transf = exp)\n\n\n\n\nreproduction of amitriptyline and fibromyalgia\n\nDiscuss with Hollie why Carette 1995 is omitted from the review.\n\n\n\nShow code\n\ntar_read(w_covidence) %>% \n  filter(str_detect(study, \"care|gins\")) %>% \n  count(study)\n\n\n# A tibble: 4 × 2\n  study             n\n  <glue>        <int>\n1 carette 1986      2\n2 carette 1994      3\n3 ginsberg 1996     2\n4 ginsberg 1998     2\n\n\n\nShow code\n\ntar_load(w_obs)\n\n\n\nreproduction of third-tier analysis\n\nDiscuss with Hollie scale labelling of Carette 1986; is analog scale 1-10 the same as vas?\n\n\n\nShow code\n\nneuropathic_dat <- \nw_obs %>% \n  filter(condition_general == \"fibromyalgia\", \n         str_detect(arm, \"placebo|amitrip\")) %>%\n  group_by(outcome, study) %>% \n  mutate(arms_per_study = 1:n()) %>% \n  filter(max(arms_per_study) > 1) %>% \n  # select(-arms_per_study) %>% \n  ungroup()\n\n\n\n\n\nShow code\n\n# look for studies\nneuropathic_dat %>% \n  filter(str_detect(study, \"care|gins\"), str_detect(outcome, \"pain\")) %>% \n  select(outcome, study) %>% \n  distinct()\n\n\n# A tibble: 3 × 2\n  outcome  study        \n  <chr>    <glue>       \n1 pain_int ginsberg 1996\n2 pain_int carette 1986 \n3 pain_int carette 1994 \n\n\n\nShow code\n\nthree_studies_dat <- \nneuropathic_dat %>% \n  filter(str_detect(study, \"care|gins\"), str_detect(outcome, \"pain\")) %>% \n  select(study, arm, covidence, scale, mean, n, sd, intervention, type)\n\n\n\n\nLook into multilevel variance-covariance matrix structure\n\n\n\nShow code\n\nthree_studies_dat %>% \n  filter(type != \"placebo\") %>% \n  left_join(\n    three_studies_dat %>% \n      filter(type == \"placebo\") %>% \n      select(study, covidence, mean_p = mean, n_p = n, sd_p = sd),\n    by = c(\"study\", \"covidence\")\n  ) %>% \n  escalc(\n    m1i = mean,\n    sd1i = sd,\n    n1i = n,\n    m2i = mean_p,\n    sd2i = sd_p,\n    n2i = n_p,\n    measure = \"SMD\",\n    data = .,\n    slab = study\n  ) %>% \n  rma.mv(\n    yi,\n    vi,\n    random = ~ 1 | study/covidence,\n    data = .\n  ) %>% forest()\n\n\n\n\nreproduction with all studies\n\n\nShow code\n\nall_dat <- neuropathic_dat %>% \n  filter(str_detect(outcome, \"pain\")) %>% \n  select(study, arm, covidence, scale, mean, n, sd, intervention, type) \n\nall_dat_rma <- \nall_dat %>% \n  filter(type != \"placebo\") %>% \n  left_join(\n    all_dat %>% \n      filter(type == \"placebo\") %>% \n      select(study, covidence, mean_p = mean, n_p = n, sd_p = sd),\n    by = c(\"study\", \"covidence\")\n  ) %>% \n  escalc(\n    m1i = mean,\n    sd1i = sd,\n    n1i = n,\n    m2i = mean_p,\n    sd2i = sd_p,\n    n2i = n_p,\n    measure = \"SMD\",\n    data = .,\n    slab = study\n  ) %>% \n  rma.mv(\n    yi = yi,\n    V = vi,\n    random = ~ 1 |study/ covidence,\n    data = .\n  ) \n\n\nsummary(all_dat_rma)\n\n\n\nMultivariate Meta-Analysis Model (k = 6; method: REML)\n\n  logLik  Deviance       AIC       BIC      AICc \n -2.3853    4.7707   10.7707    9.5990   34.7707   \n\nVariance Components:\n\n            estim    sqrt  nlvls  fixed           factor \nsigma^2.1  0.3159  0.5621      4     no            study \nsigma^2.2  0.0000  0.0000      6     no  study/covidence \n\nTest for Heterogeneity:\nQ(df = 5) = 15.2416, p-val = 0.0094\n\nModel Results:\n\nestimate      se     zval    pval    ci.lb   ci.ub \n -0.5499  0.3037  -1.8104  0.0702  -1.1452  0.0454  . \n\n---\nSignif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1\n\nShow code\n\nforest(all_dat_rma)\n\n\n\n\nextension\nNow we’ll try network meta-analysis. Again, we have to solve the multi-level thing.\nnma of fibromyalgia\n\n\nShow code\n\n# get fibromyalgia data\nfibro_dat <- \nw_obs %>% \n  filter(condition_general == \"fibromyalgia\") %>%\n  group_by(outcome, study) %>% \n  mutate(arms_per_study = 1:n()) %>% \n  filter(max(arms_per_study) > 1) %>% \n  # select(-arms_per_study) %>% \n  ungroup()\n\n\n\n\n\nShow code\n\n# outcomes\nfibro_dat %>% \n  count(outcome) %>% \n  gt()\n\n\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#genwohqdwe .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#genwohqdwe .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#genwohqdwe .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#genwohqdwe .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#genwohqdwe .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#genwohqdwe .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#genwohqdwe .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#genwohqdwe .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#genwohqdwe .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#genwohqdwe .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#genwohqdwe .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#genwohqdwe .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#genwohqdwe .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#genwohqdwe .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#genwohqdwe .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#genwohqdwe .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#genwohqdwe .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#genwohqdwe .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#genwohqdwe .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#genwohqdwe .gt_left {\n  text-align: left;\n}\n\n#genwohqdwe .gt_center {\n  text-align: center;\n}\n\n#genwohqdwe .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#genwohqdwe .gt_font_normal {\n  font-weight: normal;\n}\n\n#genwohqdwe .gt_font_bold {\n  font-weight: bold;\n}\n\n#genwohqdwe .gt_font_italic {\n  font-style: italic;\n}\n\n#genwohqdwe .gt_super {\n  font-size: 65%;\n}\n\n#genwohqdwe .gt_footnote_marks {\n  font-style: italic;\n  font-weight: normal;\n  font-size: 65%;\n}\noutcome\n      n\n    adverse\n56mood\n73pain_int\n45pain_sub\n19physical\n50qol\n21sleep\n11withdrawal\n85\n\npain nma\n\n\nShow code\n\npain_sub_net <- \n  set_agd_arm(\n  data = fibro_dat %>% filter(outcome == \"pain_sub\"),\n  trt = intervention,\n  r = r,\n  n = n,\n  sample_size = n,\n  trt_ref = \"placebo\",\n  study = study\n) \n\nplot(pain_sub_net)\n\n\n\n\n\n\nShow code\n\npain_int_net <- \n  set_agd_arm(\n  data = fibro_dat %>% filter(outcome == \"pain_int\"),\n  trt = intervention,\n  y = mean,\n  se = se,\n  sample_size = n,\n  trt_ref = \"placebo\",\n  study = study\n) \n\npain_int_net\n\n\nA network with 13 AgD studies (arm-based).\n\n--------------------------------------------- AgD studies (arm-based) ---- \n Study          Treatments                              \n carette 1986   2: placebo | amitriptyline              \n carette 1994   2: placebo | amitriptyline              \n ginsberg 1996  2: placebo | amitriptyline              \n ginsberg 1998  2: placebo | pirlindole                 \n hannonen 1998  3: moclobemide | amitriptyline | placebo\n kayiran 2010   1: escitalopram                         \n matthey 2013   2: placebo | milnacipran                \n mease 2009     2: placebo | milnacipran                \n pickering 2018 2: placebo | milnacipran                \n shakiba 2018   1: duloxetine                           \n ... plus 3 more studies\n\n Outcome type: continuous\n--------------------------------------------------------------------------\nTotal number of treatments: 9\nTotal number of studies: 13\nReference treatment is: placebo\nNetwork is disconnected\n\nShow code\n\nplot(pain_int_net)\n\n\n\n\n\n\nShow code\n\nprint(pain_int_rma)\n\n\nA random effects NMA with a normal likelihood (identity link).\nInference for Stan model: normal.\n4 chains, each with iter=2000; warmup=1000; thin=1; \npost-warmup draws per chain=1000, total post-warmup draws=4000.\n\n                    mean se_mean    sd    2.5%     25%     50%\nd[amitriptyline]    3.23    0.13  4.51   -5.67    0.09    3.19\nd[duloxetine]       0.31    0.15 10.22  -19.34   -6.67    0.39\nd[escitalopram]     0.09    0.16 10.00  -19.22   -6.82    0.00\nd[fluoxetine]       0.39    0.13  7.40  -14.06   -4.60    0.58\nd[milnacipran]     -3.96    0.18  4.75  -13.08   -7.15   -4.10\nd[mirtazapine]      3.67    0.13  7.81  -11.84   -1.59    3.60\nd[moclobemide]      4.67    0.14  6.53   -8.15    0.40    4.81\nd[pirlindole]      -0.64    0.13  7.57  -15.72   -5.75   -0.50\nlp__             -135.02    0.19  5.86 -147.98 -138.72 -134.67\ntau                11.59    0.04  1.55    8.93   10.49   11.47\n                     75%   97.5% n_eff Rhat\nd[amitriptyline]    6.27   12.20  1174    1\nd[duloxetine]       7.22   20.29  4418    1\nd[escitalopram]     6.76   20.09  4134    1\nd[fluoxetine]       5.34   14.96  3175    1\nd[milnacipran]     -0.83    5.46   737    1\nd[mirtazapine]      9.03   18.81  3524    1\nd[moclobemide]      8.86   17.50  2065    1\nd[pirlindole]       4.54   13.85  3182    1\nlp__             -130.83 -124.73   960    1\ntau                12.56   14.88  1328    1\n\nSamples were drawn using NUTS(diag_e) at Tue Jul 27 15:40:02 2021.\nFor each parameter, n_eff is a crude measure of effective sample size,\nand Rhat is the potential scale reduction factor on split chains (at \nconvergence, Rhat=1).\n\nShow code\n\nrelative_effects(pain_int_rma) %>% \n  plot()\n\n\n\n\n\n\nShow code\n\n# gussy up the plot a bit\nsummary(pain_int_rma) %>% \n  as_tibble()\n\n\n# A tibble: 50 × 11\n   parameter     mean     sd `2.5%` `25%` `50%` `75%` `97.5%` Bulk_ESS\n   <chr>        <dbl>  <dbl>  <dbl> <dbl> <dbl> <dbl>   <dbl>    <dbl>\n 1 mu[carette …  4.99  0.535   3.94  4.63  4.98  5.36    6.05    7327.\n 2 mu[carette …  2.56  0.163   2.24  2.44  2.56  2.67    2.89    7897.\n 3 mu[ginsberg…  7.00  0.276   6.47  6.81  7.00  7.19    7.54    7197.\n 4 mu[ginsberg…  6.79  0.286   6.23  6.59  6.79  6.97    7.35    8188.\n 5 mu[hannonen…  5.52  0.397   4.74  5.26  5.52  5.78    6.30    7191.\n 6 mu[kayiran …  4.00 14.1   -23.6  -5.47  4.30 13.6    31.0     2597.\n 7 mu[matthey … 52.9   2.77   47.4  51.1  52.9  54.8    58.4     4674.\n 8 mu[mease 20… 51.8   0.110  51.6  51.7  51.8  51.9    52.0     8070.\n 9 mu[pickerin…  5.60  0.361   4.89  5.36  5.59  5.84    6.33    6828.\n10 mu[shakiba … 22.1  14.1    -6.11 12.6  22.2  31.3    49.9     2767.\n# … with 40 more rows, and 2 more variables: Tail_ESS <dbl>,\n#   Rhat <dbl>\n\n\n\n\nMoore, R. Andrew, Sheena Derry, Dominic Aldington, Peter Cole, and Philip J. Wiffen. 2015. “Amitriptyline for Fibromyalgia in Adults.” Cochrane Database of Systematic Reviews, no. 7. https://doi.org/10.1002/14651858.CD011824.\n\n\n\n\n",
      "last_modified": "2021-07-27T15:40:05+01:00"
    },
    {
      "path": "overview.html",
      "title": "overview",
      "description": "Exploratory data analysis on across all outcomes.\n",
      "author": [],
      "date": "`r Sys.Date()`",
      "contents": "\n\nContents\nparticipants and conditions\n\n\n\n\nparticipants and conditions\n\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#svurnpmxoe .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#svurnpmxoe .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#svurnpmxoe .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_col_heading {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#svurnpmxoe .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#svurnpmxoe .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#svurnpmxoe .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#svurnpmxoe .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#svurnpmxoe .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#svurnpmxoe .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#svurnpmxoe .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#svurnpmxoe .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#svurnpmxoe .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#svurnpmxoe .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#svurnpmxoe .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#svurnpmxoe .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#svurnpmxoe .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#svurnpmxoe .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#svurnpmxoe .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#svurnpmxoe .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#svurnpmxoe .gt_left {\n  text-align: left;\n}\n\n#svurnpmxoe .gt_center {\n  text-align: center;\n}\n\n#svurnpmxoe .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#svurnpmxoe .gt_font_normal {\n  font-weight: normal;\n}\n\n#svurnpmxoe .gt_font_bold {\n  font-weight: bold;\n}\n\n#svurnpmxoe .gt_font_italic {\n  font-style: italic;\n}\n\n#svurnpmxoe .gt_super {\n  font-size: 65%;\n}\n\n#svurnpmxoe .gt_footnote_marks {\n  font-style: italic;\n  font-weight: normal;\n  font-size: 65%;\n}\nOutcomes and conditions\n    Number of participants, studies, and interventions in for each\n        condition in each outcome\n    \n      \n        placebo\n      \n      \n        intervention\n      \n      interventions\n      classes\n      \n        total\n      \n    participants\n      studies\n      interventions\n      participants\n      studies\n      interventions\n      participants\n      studies\n      interventions\n    adverse\n    neuropathic\n809\n7\n1\n2221\n15\n4\namitriptyline; duloxetine; venlafaxine; desvenlafaxine\ntca; snri\n3030\n15\n5Total\n      809\n      7\n      1\n      2,221\n      15\n      4\n      —\n      —\n      3,030\n      15\n      5\n    mood\n    neuropathic\n164\n3\n1\n1013\n10\n5\namitriptyline; duloxetine; citalopram; venlafaxine; duloxetine\n\ntca; snri; ssri\n1177\n10\n6Total\n      164\n      3\n      1\n      1,013\n      10\n      5\n      —\n      —\n      1,177\n      10\n      6\n    pain_int\n    neuropathic\n23\n1\n1\n434\n6\n5\namitriptyline; citalopram; nortriptyline; duloxetine; duloxetine\n\ntca; ssri; snri\n457\n6\n6Total\n      23\n      1\n      1\n      434\n      6\n      5\n      —\n      —\n      457\n      6\n      6\n    pain_sub\n    neuropathic\n622\n4\n1\n1446\n7\n2\nduloxetine; venlafaxine\nsnri\n2068\n7\n3Total\n      622\n      4\n      1\n      1,446\n      7\n      2\n      —\n      —\n      2,068\n      7\n      3\n    physical\n    neuropathic\n366\n5\n1\n768\n7\n3\nduloxetine; amitriptyline; duloxetine\n\nsnri; tca\n1134\n7\n4Total\n      366\n      5\n      1\n      768\n      7\n      3\n      —\n      —\n      1,134\n      7\n      4\n    qol\n    neuropathic\n447\n4\n1\n811\n5\n1\nduloxetine\nsnri\n1258\n5\n2Total\n      447\n      4\n      1\n      811\n      5\n      1\n      —\n      —\n      1,258\n      5\n      2\n    withdrawal\n    neuropathic\n1262\n15\n1\n3115\n26\n8\namitriptyline; trazodone; duloxetine; desipramine; fluoxetine; venlafaxine; nortriptyline; desvenlafaxine\ntca; sari; snri; ssri\n4377\n26\n9Total\n      1,262\n      15\n      1\n      3,115\n      26\n      8\n      —\n      —\n      4,377\n      26\n      9\n    \n\n\n\n\n",
      "last_modified": "2021-07-19T20:37:08+01:00"
    },
    {
      "path": "pipeline.html",
      "title": "pipeline design",
      "description": "Overview of pipeline from raw data to models.\n",
      "author": [],
      "date": "`r Sys.Date()`",
      "contents": "\n\n\nlibrary(tidyverse)\nlibrary(targets)\nlibrary(gt)\n\nsource(\"R/hpp_themes.R\")\n\n\n\nobjective\nGoal is to produce a table in the format:\noutcome\nstudy\narm\nobservations\nobservation info\nstudy-level descriptors\noutcome\nunique identifier for study\nunique identifier for arm\nmean, sd, counts, etc.\ntimepoint, scale, etc.\ncondition, study design (parallel/crossover), antyhing we need to filter by, subgroups, etc.\nThese data will contain everything that is included and excluded from the model, so that we may report on the systematic review overall, as well as the model results.\nColumn names need to be interpretable by everyone in the group, so that others can explore the data.\nInformation required for the review\nIn some cases, there is a column or columns that uniquely identify/provide the required data. In other, more challenging cases, we need to extract information from a substring of the observation header (column header).\n\n\ntar_read(e_variables)\n\n\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#zlrrqqizrr .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#zlrrqqizrr .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#zlrrqqizrr .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_col_heading {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#zlrrqqizrr .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#zlrrqqizrr .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#zlrrqqizrr .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#zlrrqqizrr .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#zlrrqqizrr .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#zlrrqqizrr .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#zlrrqqizrr .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#zlrrqqizrr .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#zlrrqqizrr .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#zlrrqqizrr .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#zlrrqqizrr .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#zlrrqqizrr .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#zlrrqqizrr .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#zlrrqqizrr .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#zlrrqqizrr .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#zlrrqqizrr .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#zlrrqqizrr .gt_left {\n  text-align: left;\n}\n\n#zlrrqqizrr .gt_center {\n  text-align: center;\n}\n\n#zlrrqqizrr .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#zlrrqqizrr .gt_font_normal {\n  font-weight: normal;\n}\n\n#zlrrqqizrr .gt_font_bold {\n  font-weight: bold;\n}\n\n#zlrrqqizrr .gt_font_italic {\n  font-style: italic;\n}\n\n#zlrrqqizrr .gt_super {\n  font-size: 65%;\n}\n\n#zlrrqqizrr .gt_footnote_marks {\n  font-style: italic;\n  font-weight: normal;\n  font-size: 65%;\n}\nVariable\n      Description\n      Covidence\n    model\n    study\n\nUnique identifier for study; comments contains title, study identifier is first author and year\nStudy Identifier + Comments\nintervention\n\nName of intervention drug: e.g., Desvenlafaxin\nIntervention Name\nfilter\n    timepoint\n\nShort-term follow up, baseline, long-term follow up, post-intervention; atm the other time points are filtered out and just postintervention is going through to the anlaysis\nobs header\nscale\n\nWe searched the column headers for names of scales (such as vas)\nobs header\ntype\n\nType of intervention: e.g., antidepressant, placebo, CBT\nIntervention Type\ndesign\n\ncrossover or parallel; for now we filter parallel not crossover\nGroup\nsubgroup\n    condition\n\nCondition of pain in the study, such as lower back pain. NB condition can be tagged in multiple ways, see condition classifier gs. In particular prioritise general_grouping as the condition variable.\ntemporomandibular disorder\nChronic pain condition(s)\nclass\n\nClass of antidepressant: e.g. SNRI; this variable only applies to antidepressant\nIntervention Class\nmain_aim\n\nPrimary aim of the original study: e.g., pain, mood, etc.\nMain aim (Pain, mood, quality of life etc)\nVariable column indicates what the cleaned output data\n                   column headers are, the Covidence column indicates what the\n                   column is labelled as in the raw export.\n    \n\nraw data\n\n\n# all current raw files read into the pipeline \ntar_manifest(names = starts_with(\"r_\"), fields = c(name, command)) %>%\n  gt() %>% hpp_tab(vertical_divider = \"name\")\n\n\nLoading required package: dontpanic\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#mffkqjmjcm .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#mffkqjmjcm .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#mffkqjmjcm .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_col_heading {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#mffkqjmjcm .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#mffkqjmjcm .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#mffkqjmjcm .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#mffkqjmjcm .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#mffkqjmjcm .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#mffkqjmjcm .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#mffkqjmjcm .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#mffkqjmjcm .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#mffkqjmjcm .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#mffkqjmjcm .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#mffkqjmjcm .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mffkqjmjcm .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mffkqjmjcm .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#mffkqjmjcm .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#mffkqjmjcm .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#mffkqjmjcm .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#mffkqjmjcm .gt_left {\n  text-align: left;\n}\n\n#mffkqjmjcm .gt_center {\n  text-align: center;\n}\n\n#mffkqjmjcm .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#mffkqjmjcm .gt_font_normal {\n  font-weight: normal;\n}\n\n#mffkqjmjcm .gt_font_bold {\n  font-weight: bold;\n}\n\n#mffkqjmjcm .gt_font_italic {\n  font-style: italic;\n}\n\n#mffkqjmjcm .gt_super {\n  font-size: 65%;\n}\n\n#mffkqjmjcm .gt_footnote_marks {\n  font-style: italic;\n  font-weight: normal;\n  font-size: 65%;\n}\nname\n      command\n    r_h_outcome_withdrawal\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Withdrawal.csv\")))r_h_outcome_physical\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Physical function.csv\")))r_h_outcome_adverse\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Adverse Events.csv\")))r_h_outcome_mood\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Mood.csv\"),  \\n     ))r_h_outcome_pain_int\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Pain intensity.csv\")))r_h_outcome_pain_sub\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Substantial pain relief.csv\")))r_h_outcome_qol\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Quality of life.csv\")))r_h_outcome_sleep\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Sleep.csv\")))r_scales\nread_rds(\"data/scales-2021-07-14_00:04:08.rds\")r_covidence\nsuppressWarnings(suppressMessages(read_csv(\"data/review_91309_extracted_data_csv_20210712234312.csv\")))r_variables\nread_csv(\"data/variables-2021-07-12_16:37:56.csv\")r_condition\nread_csv(\"data/conditions-2021-07-12_16:37:56.csv\")r_h_outcome_pain_mod\nsuppressWarnings(suppressMessages(read_csv(\"data/outcomes-2021-07-12/Moderate pain relief.csv\")))r_h_outcome_obs\nlist(mood = r_h_outcome_mood, pain_int = r_h_outcome_pain_int,  \\n     adverse = r_h_outcome_adverse, physical = r_h_outcome_physical,  \\n     qol = r_h_outcome_qol, sleep = r_h_outcome_sleep, pain_mod = w_h_outcome_pain_mod,  \\n     withdrawal = r_h_outcome_withdrawal, pain_sub = r_h_outcome_pain_sub)\n\nmodel input data\nObservations are drawn from the raw files provided by Hollie, and study-level information from the raw Covidence export, as well as column headers in the observations.\nTo do this we will join by matching the study and arm columns in two tables.\n\n\ntar_read(p_metapar)\n\n\n# A tibble: 1 × 7\n  study      arm       type     design condition    class   main_aim  \n  <chr>      <chr>     <chr>    <chr>  <chr>        <chr>   <chr>     \n1 unique st… unique a… Interve… Group  Chronic pai… Interv… Main aim …\n\nWith outcome-level observational data:\n\n\ntar_read(p_obs)\n\n\n# A tibble: 1 × 5\n  outcome    study      arm      obs             obs_info             \n  <chr>      <chr>      <chr>    <chr>           <chr>                \n1 mood, pai… unique st… unique … columns with m… \"information extract…\n\nmodel parameters\nWe’ll construct a dataframe to run models over that contains all combinations of unique subgroups we wish to run network meta-analyses over.\nIdeally this will be implemented in a shiny app.\n\n\n\n",
      "last_modified": "2021-07-25T12:59:04+01:00"
    },
    {
      "path": "wrangling.html",
      "title": "wrangling",
      "description": "Data cleaning of observations and study-level information.\n",
      "author": [
        {
          "name": "Nora Jones",
          "url": "https://example.com/norajones"
        }
      ],
      "date": "`r Sys.Date()`",
      "contents": "\n\n\nlibrary(tidyverse)\nlibrary(targets)\nlibrary(gt)\n\nsource(\"R/hpp_themes.R\")\n\n\n\nstudy\nThere’s a shorthand tag for study (first author and year) that we’ll use for the labelling in the forest plots and joining the different datasets, however, this tag is not unique.\nSo, the study tag appends with a number if there is more than one study by that author in a year.\n\n\ntar_read(w_study_key) %>% \n  filter(str_detect(study, \"Arnold\")) %>%\n  mutate(title = str_trunc(title, width = 30)) %>% \n  gt() %>% \n  hpp_tab(vertical_divider = \"study\")\n\n\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#rvpvzraiqd .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#rvpvzraiqd .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#rvpvzraiqd .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_col_heading {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#rvpvzraiqd .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #ecf2f8;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#rvpvzraiqd .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#rvpvzraiqd .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#rvpvzraiqd .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#rvpvzraiqd .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#rvpvzraiqd .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #d9e6f2;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#rvpvzraiqd .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#rvpvzraiqd .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#rvpvzraiqd .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#rvpvzraiqd .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#rvpvzraiqd .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#rvpvzraiqd .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#rvpvzraiqd .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#rvpvzraiqd .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#rvpvzraiqd .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#rvpvzraiqd .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#rvpvzraiqd .gt_left {\n  text-align: left;\n}\n\n#rvpvzraiqd .gt_center {\n  text-align: center;\n}\n\n#rvpvzraiqd .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#rvpvzraiqd .gt_font_normal {\n  font-weight: normal;\n}\n\n#rvpvzraiqd .gt_font_bold {\n  font-weight: bold;\n}\n\n#rvpvzraiqd .gt_font_italic {\n  font-style: italic;\n}\n\n#rvpvzraiqd .gt_super {\n  font-size: 65%;\n}\n\n#rvpvzraiqd .gt_footnote_marks {\n  font-style: italic;\n  font-weight: normal;\n  font-size: 65%;\n}\nstudy_identifier\n      comments\n      study\n      title\n    Arnold 2002\nTitle: A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia\nArnold 2002\nA randomized, placebo-contr...Arnold 2004\nTitle: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder\nArnold 2004\nA double-blind, multicenter...Arnold 2005\nTitle: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder\nArnold 2005\nA randomized, double-blind,...Arnold 2010\nTitle: Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study\nArnold 2010 : 1\nSafety and efficacy of esre...Arnold 2010\nTitle: Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial\nArnold 2010 : 2\nEfficacy and safety of miln...Arnold 2010\nTitle: Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial\nArnold 2010 : 3\nFlexible dosed duloxetine i...Arnold 2012\nTitle: Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study\nArnold 2012 : 1\nEfficacy and safety of dulo...Arnold 2012\nTitle: Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial\nArnold 2012 : 2\nSafety and efficacy of esre...\n\nThis function is used to construct a study key, and variables are relabelled in the study-level data extracted from Covidence, and the outcome observations extracted by Hollie.\n\n\ntar_visnetwork(allow = c(\n  starts_with(\"r_h_\"),\n  contains(\"covidence\"),\n  starts_with(\"w_study_\"),\n  contains(\"outcome\")\n))\n\n\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n|\nLoading required package: dontpanic\n\n/\n\n-\n\n\\\n\n|\n\n/\n\n \n\n{\"x\":{\"nodes\":{\"name\":[\"e_outcome_condition\",\"e_outcome_condition_all_types\",\"e_outcome_condition_counts\",\"e_outcome_condition_intervention\",\"e_outcome_condition_placebo\",\"e_outcome_condition_tab\",\"m_dat_outcome\",\"r_covidence\",\"r_h_outcome_adverse\",\"r_h_outcome_mood\",\"r_h_outcome_obs\",\"r_h_outcome_pain_int\",\"r_h_outcome_pain_mod\",\"r_h_outcome_pain_sub\",\"r_h_outcome_physical\",\"r_h_outcome_qol\",\"r_h_outcome_sleep\",\"r_h_outcome_withdrawal\",\"w_covidence\",\"w_h_outcome_pain_mod\",\"w_outcome_obs\",\"w_outcomes\",\"w_study_arm_par\",\"w_study_key\",\"w_study_label_obs\",\"w_study_label_study_arm_par\"],\"type\":[\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"pattern\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"pattern\",\"stem\",\"stem\",\"stem\",\"pattern\",\"stem\"],\"status\":[\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\"],\"seconds\":[0.007,0.025,0.02,0.01,0.014,0.181,0.04,4.994,0.048,0.953,0.001,1.225,0.065,0.068,0.445,0.257,0.318,0.031,5.599,0.003,3.704,0.001,0.031,0.082,0.275,0.008],\"bytes\":[561,434,560,484,295,6676,69869,569850,16198,69509,317584,93298,7602,15533,38617,29327,30742,14111,130267,14939,265238,119,128361,9049,193114,130526],\"branches\":[null,null,null,null,null,null,9,null,null,null,null,null,null,null,null,null,null,null,null,null,9,null,null,null,9,null],\"id\":[\"e_outcome_condition\",\"e_outcome_condition_all_types\",\"e_outcome_condition_counts\",\"e_outcome_condition_intervention\",\"e_outcome_condition_placebo\",\"e_outcome_condition_tab\",\"m_dat_outcome\",\"r_covidence\",\"r_h_outcome_adverse\",\"r_h_outcome_mood\",\"r_h_outcome_obs\",\"r_h_outcome_pain_int\",\"r_h_outcome_pain_mod\",\"r_h_outcome_pain_sub\",\"r_h_outcome_physical\",\"r_h_outcome_qol\",\"r_h_outcome_sleep\",\"r_h_outcome_withdrawal\",\"w_covidence\",\"w_h_outcome_pain_mod\",\"w_outcome_obs\",\"w_outcomes\",\"w_study_arm_par\",\"w_study_key\",\"w_study_label_obs\",\"w_study_label_study_arm_par\"],\"label\":[\"e_outcome_condition\",\"e_outcome_condition_all_types\",\"e_outcome_condition_counts\",\"e_outcome_condition_intervention\",\"e_outcome_condition_placebo\",\"e_outcome_condition_tab\",\"m_dat_outcome\",\"r_covidence\",\"r_h_outcome_adverse\",\"r_h_outcome_mood\",\"r_h_outcome_obs\",\"r_h_outcome_pain_int\",\"r_h_outcome_pain_mod\",\"r_h_outcome_pain_sub\",\"r_h_outcome_physical\",\"r_h_outcome_qol\",\"r_h_outcome_sleep\",\"r_h_outcome_withdrawal\",\"w_covidence\",\"w_h_outcome_pain_mod\",\"w_outcome_obs\",\"w_outcomes\",\"w_study_arm_par\",\"w_study_key\",\"w_study_label_obs\",\"w_study_label_study_arm_par\"],\"level\":[3,1,1,2,2,4,5,1,1,1,3,1,1,1,1,1,1,1,2,2,5,4,5,3,6,4],\"color\":[\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\"],\"shape\":[\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"square\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"square\",\"dot\",\"dot\",\"dot\",\"square\",\"dot\"]},\"edges\":{\"from\":[\"e_outcome_condition_all_types\",\"e_outcome_condition_intervention\",\"e_outcome_condition_placebo\",\"r_h_outcome_pain_mod\",\"r_h_outcome_withdrawal\",\"e_outcome_condition\",\"w_covidence\",\"w_study_key\",\"e_outcome_condition_counts\",\"r_h_outcome_obs\",\"e_outcome_condition_counts\",\"w_outcome_obs\",\"w_study_key\",\"r_h_outcome_obs\",\"w_outcomes\",\"w_study_label_study_arm_par\",\"w_covidence\",\"w_outcomes\",\"r_covidence\",\"r_h_outcome_adverse\",\"r_h_outcome_mood\",\"r_h_outcome_pain_int\",\"r_h_outcome_pain_sub\",\"r_h_outcome_physical\",\"r_h_outcome_qol\",\"r_h_outcome_sleep\",\"r_h_outcome_withdrawal\",\"w_h_outcome_pain_mod\"],\"to\":[\"e_outcome_condition\",\"e_outcome_condition\",\"e_outcome_condition\",\"w_h_outcome_pain_mod\",\"w_h_outcome_pain_mod\",\"e_outcome_condition_tab\",\"w_study_label_study_arm_par\",\"w_study_label_study_arm_par\",\"e_outcome_condition_placebo\",\"w_outcomes\",\"e_outcome_condition_intervention\",\"w_study_label_obs\",\"w_study_label_obs\",\"w_outcome_obs\",\"w_outcome_obs\",\"w_study_arm_par\",\"w_study_key\",\"m_dat_outcome\",\"w_covidence\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\",\"r_h_outcome_obs\"],\"arrows\":[\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\"]},\"nodesToDataframe\":true,\"edgesToDataframe\":true,\"options\":{\"width\":\"100%\",\"height\":\"100%\",\"nodes\":{\"shape\":\"dot\",\"physics\":false},\"manipulation\":{\"enabled\":false},\"edges\":{\"smooth\":{\"type\":\"cubicBezier\",\"forceDirection\":\"horizontal\"}},\"physics\":{\"stabilization\":false},\"layout\":{\"hierarchical\":{\"enabled\":true,\"direction\":\"LR\"}}},\"groups\":null,\"width\":null,\"height\":null,\"idselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"useLabels\":true,\"main\":\"Select by id\"},\"byselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"multiple\":false,\"hideColor\":\"rgba(200,200,200,0.5)\",\"highlight\":false},\"main\":{\"text\":\"\",\"style\":\"font-family:Georgia, Times New Roman, Times, serif;font-weight:bold;font-size:20px;text-align:center;\"},\"submain\":null,\"footer\":null,\"background\":\"rgba(0, 0, 0, 0)\",\"highlight\":{\"enabled\":false,\"hoverNearest\":false,\"degree\":1,\"algorithm\":\"all\",\"hideColor\":\"rgba(200,200,200,0.5)\",\"labelOnly\":true},\"collapse\":{\"enabled\":true,\"fit\":false,\"resetHighlight\":true,\"clusterOptions\":null,\"keepCoord\":true,\"labelSuffix\":\"(cluster)\"},\"legend\":{\"width\":0.2,\"useGroups\":false,\"position\":\"right\",\"ncol\":1,\"stepX\":100,\"stepY\":100,\"zoom\":true,\"nodes\":{\"label\":[\"Up to date\",\"Stem\",\"Pattern\"],\"color\":[\"#354823\",\"#899DA4\",\"#899DA4\"],\"shape\":[\"dot\",\"dot\",\"square\"]},\"nodesToDataframe\":true}},\"evals\":[],\"jsHooks\":[]}\nWe now have two datasets each with study and arm, so we can join them together later.\n\n\n# table of study/arm level information\ntar_read(w_study_label_study_arm_par)\n\n\n# A tibble: 451 x 25\n   study  arm    intervention  type    class condition main_aim design\n   <glue> <chr>  <chr>         <chr>   <chr> <chr>     <chr>    <chr> \n 1 Kayir… Neuro… <NA>          Neurof… <NA>  Fibromya… Neurofe… Paral…\n 2 Kayir… Escit… Escitalopram  Antide… SSRI  Fibromya… Neurofe… Paral…\n 3 Arnol… Place… <NA>          Placebo <NA>  Fibromya… Fibromy… Paral…\n 4 Arnol… Fluox… Fluoxetine    Antide… SSRI  Fibromya… Fibromy… Paral…\n 5 Arnol… Place… <NA>          Placebo <NA>  Fibromya… Pain     Paral…\n 6 Arnol… Esreb… Esreboxetine  Antide… SNRI  Fibromya… Pain     Paral…\n 7 Gonza… Physi… Ultrasonogra… Ultras… <NA>  Fibromya… Pain     Paral…\n 8 Gonza… Sertr… Sertraline    Antide… SSRI  Fibromya… Pain     Paral…\n 9 Hammo… Prega… Pregabalin    Antico… <NA>  Fibromya… Pain     Paral…\n10 Hammo… Amitr… Amitriptyline Antide… TCA   Fibromya… Pain     Paral…\n# … with 441 more rows, and 17 more variables:\n#   sponsorship_source <chr>, authors_name <chr>,\n#   duration_weeks <chr>, pain_duration <chr>,\n#   inclusion_criteria <chr>, exclusion_criteria <chr>,\n#   total_number_of_participants_randomised <chr>,\n#   number_in_each_arm_comparators_treatments <chr>,\n#   number_in_each_arm_intervention_comparators <chr>,\n#   type_of_participant_e_g_people_with_cancer <chr>,\n#   type_of_participant_e_g_people_with_cancer_2 <chr>,\n#   intervention_adverse_events <chr>,\n#   intervention_adverse_events_n_percent <chr>,\n#   withdrawal_total_per_arm_n_percent <chr>,\n#   withdrawal_total_percent <dbl>, withdrawal_total_n <dbl>,\n#   title <chr>\n\n# list of outcome tables with observations extracted by Hollie\ntar_read(w_study_label_obs) %>% \n  # select first 10 columns bc space\n  map(select, c(1:10))\n\n\n[[1]]\n# A tibble: 451 x 10\n   outcome study   arm       anxiety_1_item_pati… anxiety_1_item_pati…\n   <chr>   <glue>  <chr>     <lgl>                <lgl>               \n 1 mood    Lee 20… Placebo   NA                   NA                  \n 2 mood    Lee 20… Venlafax… NA                   NA                  \n 3 mood    dsrhv … Control   NA                   NA                  \n 4 mood    dsrhv … Amitript… NA                   NA                  \n 5 mood    dsrhv … Amitript… NA                   NA                  \n 6 mood    dsrhv … Acupunct… NA                   NA                  \n 7 mood    Keskin… Gabapent… NA                   NA                  \n 8 mood    Keskin… Amitript… NA                   NA                  \n 9 mood    Cannon… Placebo   NA                   NA                  \n10 mood    Cannon… Clonidine NA                   NA                  \n# … with 441 more rows, and 5 more variables:\n#   anxiety_1_item_patient_rated_ni_baseline_se <lgl>,\n#   anxiety_4_point_nrs_from_0_no_anxiety_to_3_severe_anxiety_baseline_mean <dbl>,\n#   anxiety_4_point_nrs_from_0_no_anxiety_to_3_severe_anxiety_baseline_n <dbl>,\n#   anxiety_4_point_nrs_from_0_no_anxiety_to_3_severe_anxiety_baseline_sd <dbl>,\n#   anxiety_4_point_nrs_from_0_no_anxiety_to_3_severe_anxiety_mid_intervention_week_3_mean <dbl>\n\n[[2]]\n# A tibble: 451 x 10\n   outcome  study  arm     american_college_of_… american_college_of_…\n   <chr>    <glue> <chr>                   <dbl>                 <dbl>\n 1 pain_int Lee 2… Placebo                    NA                    NA\n 2 pain_int Lee 2… Venlaf…                    NA                    NA\n 3 pain_int dsrhv… Control                    NA                    NA\n 4 pain_int dsrhv… Amitri…                    NA                    NA\n 5 pain_int dsrhv… Amitri…                    NA                    NA\n 6 pain_int dsrhv… Acupun…                    NA                    NA\n 7 pain_int Keski… Gabape…                    NA                    NA\n 8 pain_int Keski… Amitri…                    NA                    NA\n 9 pain_int Canno… Placebo                    NA                    NA\n10 pain_int Canno… Clonid…                    NA                    NA\n# … with 441 more rows, and 5 more variables:\n#   american_college_of_rheumatology_acr_fibromyalgia_widespread_pain_index_wpi_baseline_sd <dbl>,\n#   american_college_of_rheumatology_acr_fibromyalgia_widespread_pain_index_wpi_post_intervention_ls_mean_se_change_from_baseline_mean <dbl>,\n#   american_college_of_rheumatology_acr_fibromyalgia_widespread_pain_index_wpi_post_intervention_ls_mean_se_change_from_baseline_n <dbl>,\n#   american_college_of_rheumatology_acr_fibromyalgia_widespread_pain_index_wpi_post_intervention_ls_mean_se_change_from_baseline_sd <dbl>,\n#   average_of_pain_rating_index_mc_gill_pain_questionnaire_itt_sample_baseline_mean <dbl>\n\n[[3]]\n# A tibble: 451 x 10\n   outcome study   arm        adverse_drug_reacti… adverse_drug_react…\n   <chr>   <glue>  <chr>                     <dbl>               <dbl>\n 1 adverse Lee 20… Placebo                      NA                  NA\n 2 adverse Lee 20… Venlafaxi…                   NA                  NA\n 3 adverse dsrhv … Control                      NA                  NA\n 4 adverse dsrhv … Amitripty…                   NA                  NA\n 5 adverse dsrhv … Amitripty…                   NA                  NA\n 6 adverse dsrhv … Acupunctu…                   NA                  NA\n 7 adverse Keskin… Gabapenti…                   NA                  NA\n 8 adverse Keskin… Amitripty…                   NA                  NA\n 9 adverse Cannon… Placebo                      NA                  NA\n10 adverse Cannon… Clonidine                    NA                  NA\n# … with 441 more rows, and 5 more variables:\n#   adverse_effects_physician_rated_with_the_dotes_endpoint_percent <dbl>,\n#   adverse_effects_physician_rated_with_the_dotes_endpoint_n <dbl>,\n#   adverse_events_endpoint_percent <dbl>,\n#   adverse_events_endpoint_n <dbl>,\n#   adverse_events_3_months_acute_phase_post_intervention_percent <dbl>\n\n[[4]]\n# A tibble: 451 x 10\n   outcome  study  arm     activity_change_in_a… activity_change_in_a…\n   <chr>    <glue> <chr>                   <dbl>                 <dbl>\n 1 physical Arnol… Placebo                    NA                    NA\n 2 physical Arnol… Esrebo…                    NA                    NA\n 3 physical Gonza… Physic…                    NA                    NA\n 4 physical Gonza… Sertra…                    NA                    NA\n 5 physical Hammo… Pregab…                    NA                    NA\n 6 physical Hammo… Amitri…                    NA                    NA\n 7 physical Carde… Benzot…                    NA                    NA\n 8 physical Carde… Amitri…                    NA                    NA\n 9 physical Gould… Benzot…                    NA                    NA\n10 physical Gould… Desipr…                    NA                    NA\n# … with 441 more rows, and 5 more variables:\n#   activity_change_in_activity_in_daily_lives_post_intervention_unchanged_percent <dbl>,\n#   activity_change_in_activity_in_daily_lives_post_intervention_unchanged_n <dbl>,\n#   activity_change_in_activity_in_daily_lives_post_intervention_worse_percent <dbl>,\n#   activity_change_in_activity_in_daily_lives_post_intervention_worse_n <dbl>,\n#   activity_vas_0_100_baseline_mean <lgl>\n\n[[5]]\n# A tibble: 451 x 10\n   outcome study   arm      fibromyalgia_impact_… fibromyalgia_impact…\n   <chr>   <glue>  <chr>                    <dbl> <lgl>               \n 1 qol     Arnold… Placebo                     NA NA                  \n 2 qol     Arnold… Esrebox…                    NA NA                  \n 3 qol     Gonzal… Physica…                    NA NA                  \n 4 qol     Gonzal… Sertral…                    NA NA                  \n 5 qol     Hammod… Pregaba…                    NA NA                  \n 6 qol     Hammod… Amitrip…                    NA NA                  \n 7 qol     Carden… Benzotr…                    NA NA                  \n 8 qol     Carden… Amitrip…                    NA NA                  \n 9 qol     Gould … Benzotr…                    NA NA                  \n10 qol     Gould … Desipra…                    NA NA                  \n# … with 441 more rows, and 5 more variables:\n#   fibromyalgia_impact_50_percent_reduction_in_fiq_baseline_percent <dbl>,\n#   fibromyalgia_impact_50_percent_reduction_in_fiq_baseline_n <dbl>,\n#   fibromyalgia_impact_fibromyalgia_impact_questionnaire_fiq_baseline_mean <dbl>,\n#   fibromyalgia_impact_fibromyalgia_impact_questionnaire_fiq_baseline_n <dbl>,\n#   fibromyalgia_impact_fibromyalgia_impact_questionnaire_fiq_baseline_sd <dbl>\n\n[[6]]\n# A tibble: 451 x 10\n   outcome study  arm      change_from_baseline… change_from_baseline…\n   <chr>   <glue> <chr>    <lgl>                 <lgl>                \n 1 sleep   Lee 2… Placebo  NA                    NA                   \n 2 sleep   Lee 2… Venlafa… NA                    NA                   \n 3 sleep   dsrhv… Control  NA                    NA                   \n 4 sleep   dsrhv… Amitrip… NA                    NA                   \n 5 sleep   dsrhv… Amitrip… NA                    NA                   \n 6 sleep   dsrhv… Acupunc… NA                    NA                   \n 7 sleep   <NA>   Gabapen… NA                    NA                   \n 8 sleep   <NA>   Amitrip… NA                    NA                   \n 9 sleep   Canno… Placebo  NA                    NA                   \n10 sleep   Canno… Clonidi… NA                    NA                   \n# … with 441 more rows, and 5 more variables:\n#   change_from_baseline_in_the_endpoint_mean_sleep_interference_score_nr_protocol_only_endpoint_se <lgl>,\n#   change_in_sleep_pattern_baseline_percent <lgl>,\n#   change_in_sleep_pattern_baseline_n <lgl>,\n#   change_in_sleep_pattern_decreased_percent <lgl>,\n#   change_in_sleep_pattern_decreased_n <lgl>\n\n[[7]]\n     outcome study                                       arm\n1   pain_mod  <NA>                                   Placebo\n2   pain_mod  <NA>                        Venlafaxine - 75mg\n3   pain_mod  <NA>                                   Control\n4   pain_mod  <NA>                        Amitriptyline 10mg\n5   pain_mod  <NA>               Amitriptyline 10mg + splint\n6   pain_mod  <NA>                               Acupuncture\n7   pain_mod  <NA>                   Gabapentin 900 – 3600mg\n8   pain_mod  <NA>                  Amitriptyline 25 – 150mg\n9   pain_mod  <NA>                                   Placebo\n10  pain_mod  <NA>                                 Clonidine\n11  pain_mod  <NA>                           Imipramine 50mg\n12  pain_mod  <NA>                                   Placebo\n13  pain_mod  <NA>                        Amitriptyline 75mg\n14  pain_mod  <NA>                                   Placebo\n15  pain_mod  <NA>                       Amitriptyline 100mg\n16  pain_mod  <NA>                        Gabapentin ≤3600mg\n17  pain_mod  <NA>                      Amitriptyline ≤150mg\n18  pain_mod  <NA>                     Diphenhydramine ≤75mg\n19  pain_mod  <NA>                                   Placebo\n20  pain_mod  <NA>                  Venlafaxine 37.5 - 225mg\n21  pain_mod  <NA>                                   Placebo\n22  pain_mod  <NA>                           Paroxetine 20mg\n23  pain_mod  <NA> Benztropine mesylate 0.5 [active placebo]\n24  pain_mod  <NA>                         Desipramine - low\n25  pain_mod  <NA>                      Desipramine - medium\n26  pain_mod  <NA>                        Desipramine - high\n27  pain_mod  <NA>                          Fluoxetine - low\n28  pain_mod  <NA>                       Fluoxetine - medium\n29  pain_mod  <NA>                         Fluoxetine - high\n30  pain_mod  <NA>                                   Placebo\n31  pain_mod  <NA>                    Fluvoxamine - 50-150mg\n32  pain_mod  <NA>                          Physical Therapy\n33  pain_mod  <NA>                         Sertraline - 50mg\n34  pain_mod  <NA>                     Amitriptyline - ≥10mg\n35  pain_mod  <NA>                     Nortriptyline - ≥10mg\n36  pain_mod  <NA>                                   Placebo\n37  pain_mod  <NA>                             Amitriptyline\n38  pain_mod  <NA>                   Amitriptyline (Group 1)\n39  pain_mod  <NA>    Amitriptyline + Fluphenazine (Group 2)\n40  pain_mod  <NA>                    Fluphenazine (Group 3)\n41  pain_mod  <NA>  Glycopyrrolate (Active Placebo; Group 4)\n42  pain_mod  <NA>                         Riboflavin - 15mg\n43  pain_mod  <NA>  Amitriptyline - 75mg + Riboflavin - 15mg\n44  pain_mod  <NA>            Amitriptyline - 25mg + Placebo\n45  pain_mod  <NA>               Fluoxetine - 20mg + Placebo\n46  pain_mod  <NA>                                   Placebo\n47  pain_mod  <NA>                       Milnacipran - 100mg\n48  pain_mod  <NA>                                   Placebo\n49  pain_mod  <NA>            Amitriptyline - 25mg + Placebo\n50  pain_mod  <NA>               Fluoxetine - 20mg + Placebo\n51  pain_mod  <NA>  Amitriptyline - 25mg + Fluoxetine - 20mg\n52  pain_mod  <NA>                                   Placebo\n53  pain_mod  <NA>                        Imipramine - 150mg\n54  pain_mod  <NA>                                   Placebo\n55  pain_mod  <NA>                          Dothiepin - 75mg\n56  pain_mod  <NA>                  Desipramine 12.5 - 150mg\n57  pain_mod  <NA>                Amitriptyline 12.5 - 150mg\n58  pain_mod  <NA>                                   Placebo\n59  pain_mod  <NA>                           Trazodone 200mg\n60  pain_mod  <NA>            Amitriptyline + naproxen (A+N)\n61  pain_mod  <NA>                    Placebo + naproxen (N)\n62  pain_mod  <NA>               Amitriptyline + placebo (A)\n63  pain_mod  <NA>                    Placebo + placebo (PL)\n64  pain_mod  <NA>                    Milnacipran 50 - 200mg\n65  pain_mod  <NA>                                   Placebo\n66  pain_mod  <NA>             Amitriptyline + pyschotherapy\n67  pain_mod  <NA>                   Amitriptyline + support\n68  pain_mod  <NA>                   Placebo + psychotherapy\n69  pain_mod  <NA>                         Placebo + support\n70  pain_mod  <NA>                   Gabapentin 900 - 1800mg\n71  pain_mod  <NA>                   Amitriptyline 25 - 75mg\n72  pain_mod  <NA>                                   Doxepin\n73  pain_mod  <NA>                               Desipramine\n74  pain_mod  <NA>                                   Placebo\n75  pain_mod  <NA>            Milnacipran 25-200mg/day [q.d]\n76  pain_mod  <NA>          Milnacipran 25-200mg/day [b.i.d]\n77  pain_mod  <NA>                Aerobic exercise (Group I)\n78  pain_mod  <NA>                Paroxetine 20mg (Group II)\n79  pain_mod  <NA>                  Placebo TENS (Group III)\n80  pain_mod  <NA>                             Amitriptyline\n81  pain_mod  <NA>                               Maprotiline\n82  pain_mod  <NA>                                   Placebo\n83  pain_mod  <NA>                         Imipramine - 50mg\n84  pain_mod  <NA>                         Citalopram - 40mg\n85  pain_mod  <NA>                                   Placebo\n86  pain_mod  <NA>                         Duloxetine - 20mg\n87  pain_mod  <NA>                         Duloxetine - 60mg\n88  pain_mod  <NA>                        Duloxetine - 120mg\n89  pain_mod  <NA>                        Nabilone 0.5-1.0mg\n90  pain_mod  <NA>                     Amitriptyline 10-20mg\n91  pain_mod  <NA>                                   Placebo\n92  pain_mod  <NA>                      Escitalopram 10-20mg\n93  pain_mod  <NA>                         Benzotropine ≤1mg\n94  pain_mod  <NA>                    Morphine ≥15 and ≤90mg\n95  pain_mod  <NA>              Nortriptyline ≥25 and ≤100mg\n96  pain_mod  <NA>                  Morphine + Nortriptyline\n97  pain_mod  <NA>                                   Placebo\n98  pain_mod  <NA>                           Duloxetine 60mg\n99  pain_mod  <NA>                                   Placebo\n100 pain_mod  <NA>                           Duloxetine 60mg\n    moderate_pain_relief_30_percent_relief_baseline_percent\n1                                                        NA\n2                                                        NA\n3                                                        NA\n4                                                        NA\n5                                                        NA\n6                                                        NA\n7                                                        NA\n8                                                        NA\n9                                                        NA\n10                                                       NA\n11                                                       NA\n12                                                       NA\n13                                                       NA\n14                                                       NA\n15                                                       NA\n16                                                       NA\n17                                                       NA\n18                                                       NA\n19                                                       NA\n20                                                       NA\n21                                                       NA\n22                                                       NA\n23                                                       NA\n24                                                       NA\n25                                                       NA\n26                                                       NA\n27                                                       NA\n28                                                       NA\n29                                                       NA\n30                                                       NA\n31                                                       NA\n32                                                       NA\n33                                                       NA\n34                                                       NA\n35                                                       NA\n36                                                       NA\n37                                                       NA\n38                                                       NA\n39                                                       NA\n40                                                       NA\n41                                                       NA\n42                                                       NA\n43                                                       NA\n44                                                       NA\n45                                                       NA\n46                                                       NA\n47                                                       NA\n48                                                       NA\n49                                                       NA\n50                                                       NA\n51                                                       NA\n52                                                       NA\n53                                                       NA\n54                                                       NA\n55                                                       NA\n56                                                       NA\n57                                                       NA\n58                                                       NA\n59                                                       NA\n60                                                       NA\n61                                                       NA\n62                                                       NA\n63                                                       NA\n64                                                       NA\n65                                                       NA\n66                                                       NA\n67                                                       NA\n68                                                       NA\n69                                                       NA\n70                                                       NA\n71                                                       NA\n72                                                       NA\n73                                                       NA\n74                                                       NA\n75                                                       NA\n76                                                       NA\n77                                                       NA\n78                                                       NA\n79                                                       NA\n80                                                       NA\n81                                                       NA\n82                                                       NA\n83                                                       NA\n84                                                       NA\n85                                                       NA\n86                                                       NA\n87                                                       NA\n88                                                       NA\n89                                                       NA\n90                                                       NA\n91                                                       NA\n92                                                       NA\n93                                                       NA\n94                                                       NA\n95                                                       NA\n96                                                       NA\n97                                                       NA\n98                                                       NA\n99                                                       NA\n100                                                      NA\n    moderate_pain_relief_30_percent_relief_baseline_n\n1                                                  NA\n2                                                  NA\n3                                                  NA\n4                                                  NA\n5                                                  NA\n6                                                  NA\n7                                                  NA\n8                                                  NA\n9                                                  NA\n10                                                 NA\n11                                                 NA\n12                                                 NA\n13                                                 NA\n14                                                 NA\n15                                                 NA\n16                                                 NA\n17                                                 NA\n18                                                 NA\n19                                                 NA\n20                                                 NA\n21                                                 NA\n22                                                 NA\n23                                                 NA\n24                                                 NA\n25                                                 NA\n26                                                 NA\n27                                                 NA\n28                                                 NA\n29                                                 NA\n30                                                 NA\n31                                                 NA\n32                                                 NA\n33                                                 NA\n34                                                 NA\n35                                                 NA\n36                                                 NA\n37                                                 NA\n38                                                 NA\n39                                                 NA\n40                                                 NA\n41                                                 NA\n42                                                 NA\n43                                                 NA\n44                                                 NA\n45                                                 NA\n46                                                 NA\n47                                                 NA\n48                                                 NA\n49                                                 NA\n50                                                 NA\n51                                                 NA\n52                                                 NA\n53                                                 NA\n54                                                 NA\n55                                                 NA\n56                                                 NA\n57                                                 NA\n58                                                 NA\n59                                                 NA\n60                                                 NA\n61                                                 NA\n62                                                 NA\n63                                                 NA\n64                                                 NA\n65                                                 NA\n66                                                 NA\n67                                                 NA\n68                                                 NA\n69                                                 NA\n70                                                 NA\n71                                                 NA\n72                                                 NA\n73                                                 NA\n74                                                 NA\n75                                                 NA\n76                                                 NA\n77                                                 NA\n78                                                 NA\n79                                                 NA\n80                                                 NA\n81                                                 NA\n82                                                 NA\n83                                                 NA\n84                                                 NA\n85                                                 NA\n86                                                 NA\n87                                                 NA\n88                                                 NA\n89                                                 NA\n90                                                 NA\n91                                                 NA\n92                                                 NA\n93                                                 NA\n94                                                 NA\n95                                                 NA\n96                                                 NA\n97                                                 NA\n98                                                 NA\n99                                                 NA\n100                                                NA\n    moderate_pain_relief_30_percent_relief_of_ped_24_hr_morning_recall_scores_completers_only_15_weeks_within_trial_percent\n1                                                                                                                        NA\n2                                                                                                                        NA\n3                                                                                                                        NA\n4                                                                                                                        NA\n5                                                                                                                        NA\n6                                                                                                                        NA\n7                                                                                                                        NA\n8                                                                                                                        NA\n9                                                                                                                        NA\n10                                                                                                                       NA\n11                                                                                                                       NA\n12                                                                                                                       NA\n13                                                                                                                       NA\n14                                                                                                                       NA\n15                                                                                                                       NA\n16                                                                                                                       NA\n17                                                                                                                       NA\n18                                                                                                                       NA\n19                                                                                                                       NA\n20                                                                                                                       NA\n21                                                                                                                       NA\n22                                                                                                                       NA\n23                                                                                                                       NA\n24                                                                                                                       NA\n25                                                                                                                       NA\n26                                                                                                                       NA\n27                                                                                                                       NA\n28                                                                                                                       NA\n29                                                                                                                       NA\n30                                                                                                                       NA\n31                                                                                                                       NA\n32                                                                                                                       NA\n33                                                                                                                       NA\n34                                                                                                                       NA\n35                                                                                                                       NA\n36                                                                                                                       NA\n37                                                                                                                       NA\n38                                                                                                                       NA\n39                                                                                                                       NA\n40                                                                                                                       NA\n41                                                                                                                       NA\n42                                                                                                                       NA\n43                                                                                                                       NA\n44                                                                                                                       NA\n45                                                                                                                       NA\n46                                                                                                                       NA\n47                                                                                                                       NA\n48                                                                                                                       NA\n49                                                                                                                       NA\n50                                                                                                                       NA\n51                                                                                                                       NA\n52                                                                                                                       NA\n53                                                                                                                       NA\n54                                                                                                                       NA\n55                                                                                                                       NA\n56                                                                                                                       NA\n57                                                                                                                       NA\n58                                                                                                                       NA\n59                                                                                                                       NA\n60                                                                                                                       NA\n61                                                                                                                       NA\n62                                                                                                                       NA\n63                                                                                                                       NA\n64                                                                                                                       NA\n65                                                                                                                       NA\n66                                                                                                                       NA\n67                                                                                                                       NA\n68                                                                                                                       NA\n69                                                                                                                       NA\n70                                                                                                                       NA\n71                                                                                                                       NA\n72                                                                                                                       NA\n73                                                                                                                       NA\n74                                                                                                                       NA\n75                                                                                                                       NA\n76                                                                                                                       NA\n77                                                                                                                       NA\n78                                                                                                                       NA\n79                                                                                                                       NA\n80                                                                                                                       NA\n81                                                                                                                       NA\n82                                                                                                                       NA\n83                                                                                                                       NA\n84                                                                                                                       NA\n85                                                                                                                       NA\n86                                                                                                                       NA\n87                                                                                                                       NA\n88                                                                                                                       NA\n89                                                                                                                       NA\n90                                                                                                                       NA\n91                                                                                                                       NA\n92                                                                                                                       NA\n93                                                                                                                       NA\n94                                                                                                                       NA\n95                                                                                                                       NA\n96                                                                                                                       NA\n97                                                                                                                       NA\n98                                                                                                                       NA\n99                                                                                                                       NA\n100                                                                                                                      NA\n    moderate_pain_relief_30_percent_relief_of_ped_24_hr_morning_recall_scores_completers_only_15_weeks_within_trial_n\n1                                                                                                                  NA\n2                                                                                                                  NA\n3                                                                                                                  NA\n4                                                                                                                  NA\n5                                                                                                                  NA\n6                                                                                                                  NA\n7                                                                                                                  NA\n8                                                                                                                  NA\n9                                                                                                                  NA\n10                                                                                                                 NA\n11                                                                                                                 NA\n12                                                                                                                 NA\n13                                                                                                                 NA\n14                                                                                                                 NA\n15                                                                                                                 NA\n16                                                                                                                 NA\n17                                                                                                                 NA\n18                                                                                                                 NA\n19                                                                                                                 NA\n20                                                                                                                 NA\n21                                                                                                                 NA\n22                                                                                                                 NA\n23                                                                                                                 NA\n24                                                                                                                 NA\n25                                                                                                                 NA\n26                                                                                                                 NA\n27                                                                                                                 NA\n28                                                                                                                 NA\n29                                                                                                                 NA\n30                                                                                                                 NA\n31                                                                                                                 NA\n32                                                                                                                 NA\n33                                                                                                                 NA\n34                                                                                                                 NA\n35                                                                                                                 NA\n36                                                                                                                 NA\n37                                                                                                                 NA\n38                                                                                                                 NA\n39                                                                                                                 NA\n40                                                                                                                 NA\n41                                                                                                                 NA\n42                                                                                                                 NA\n43                                                                                                                 NA\n44                                                                                                                 NA\n45                                                                                                                 NA\n46                                                                                                                 NA\n47                                                                                                                 NA\n48                                                                                                                 NA\n49                                                                                                                 NA\n50                                                                                                                 NA\n51                                                                                                                 NA\n52                                                                                                                 NA\n53                                                                                                                 NA\n54                                                                                                                 NA\n55                                                                                                                 NA\n56                                                                                                                 NA\n57                                                                                                                 NA\n58                                                                                                                 NA\n59                                                                                                                 NA\n60                                                                                                                 NA\n61                                                                                                                 NA\n62                                                                                                                 NA\n63                                                                                                                 NA\n64                                                                                                                 NA\n65                                                                                                                 NA\n66                                                                                                                 NA\n67                                                                                                                 NA\n68                                                                                                                 NA\n69                                                                                                                 NA\n70                                                                                                                 NA\n71                                                                                                                 NA\n72                                                                                                                 NA\n73                                                                                                                 NA\n74                                                                                                                 NA\n75                                                                                                                 NA\n76                                                                                                                 NA\n77                                                                                                                 NA\n78                                                                                                                 NA\n79                                                                                                                 NA\n80                                                                                                                 NA\n81                                                                                                                 NA\n82                                                                                                                 NA\n83                                                                                                                 NA\n84                                                                                                                 NA\n85                                                                                                                 NA\n86                                                                                                                 NA\n87                                                                                                                 NA\n88                                                                                                                 NA\n89                                                                                                                 NA\n90                                                                                                                 NA\n91                                                                                                                 NA\n92                                                                                                                 NA\n93                                                                                                                 NA\n94                                                                                                                 NA\n95                                                                                                                 NA\n96                                                                                                                 NA\n97                                                                                                                 NA\n98                                                                                                                 NA\n99                                                                                                                 NA\n100                                                                                                                NA\n    number_of_responders_30_percent_improvement_in_brief_pain_inventory_average_pain_bocf_endpoint_percent\n1                                                                                                       NA\n2                                                                                                       NA\n3                                                                                                       NA\n4                                                                                                       NA\n5                                                                                                       NA\n6                                                                                                       NA\n7                                                                                                       NA\n8                                                                                                       NA\n9                                                                                                       NA\n10                                                                                                      NA\n11                                                                                                      NA\n12                                                                                                      NA\n13                                                                                                      NA\n14                                                                                                      NA\n15                                                                                                      NA\n16                                                                                                      NA\n17                                                                                                      NA\n18                                                                                                      NA\n19                                                                                                      NA\n20                                                                                                      NA\n21                                                                                                      NA\n22                                                                                                      NA\n23                                                                                                      NA\n24                                                                                                      NA\n25                                                                                                      NA\n26                                                                                                      NA\n27                                                                                                      NA\n28                                                                                                      NA\n29                                                                                                      NA\n30                                                                                                      NA\n31                                                                                                      NA\n32                                                                                                      NA\n33                                                                                                      NA\n34                                                                                                      NA\n35                                                                                                      NA\n36                                                                                                      NA\n37                                                                                                      NA\n38                                                                                                      NA\n39                                                                                                      NA\n40                                                                                                      NA\n41                                                                                                      NA\n42                                                                                                      NA\n43                                                                                                      NA\n44                                                                                                      NA\n45                                                                                                      NA\n46                                                                                                      NA\n47                                                                                                      NA\n48                                                                                                      NA\n49                                                                                                      NA\n50                                                                                                      NA\n51                                                                                                      NA\n52                                                                                                      NA\n53                                                                                                      NA\n54                                                                                                      NA\n55                                                                                                      NA\n56                                                                                                      NA\n57                                                                                                      NA\n58                                                                                                      NA\n59                                                                                                      NA\n60                                                                                                      NA\n61                                                                                                      NA\n62                                                                                                      NA\n63                                                                                                      NA\n64                                                                                                      NA\n65                                                                                                      NA\n66                                                                                                      NA\n67                                                                                                      NA\n68                                                                                                      NA\n69                                                                                                      NA\n70                                                                                                      NA\n71                                                                                                      NA\n72                                                                                                      NA\n73                                                                                                      NA\n74                                                                                                      NA\n75                                                                                                      NA\n76                                                                                                      NA\n77                                                                                                      NA\n78                                                                                                      NA\n79                                                                                                      NA\n80                                                                                                      NA\n81                                                                                                      NA\n82                                                                                                      NA\n83                                                                                                      NA\n84                                                                                                      NA\n85                                                                                                      NA\n86                                                                                                      NA\n87                                                                                                      NA\n88                                                                                                      NA\n89                                                                                                      NA\n90                                                                                                      NA\n91                                                                                                      NA\n92                                                                                                      NA\n93                                                                                                      NA\n94                                                                                                      NA\n95                                                                                                      NA\n96                                                                                                      NA\n97                                                                                                      NA\n98                                                                                                      NA\n99                                                                                                      NA\n100                                                                                                     NA\n    number_of_responders_30_percent_improvement_in_brief_pain_inventory_average_pain_bocf_endpoint_n\n1                                                                                                 NA\n2                                                                                                 NA\n3                                                                                                 NA\n4                                                                                                 NA\n5                                                                                                 NA\n6                                                                                                 NA\n7                                                                                                 NA\n8                                                                                                 NA\n9                                                                                                 NA\n10                                                                                                NA\n11                                                                                                NA\n12                                                                                                NA\n13                                                                                                NA\n14                                                                                                NA\n15                                                                                                NA\n16                                                                                                NA\n17                                                                                                NA\n18                                                                                                NA\n19                                                                                                NA\n20                                                                                                NA\n21                                                                                                NA\n22                                                                                                NA\n23                                                                                                NA\n24                                                                                                NA\n25                                                                                                NA\n26                                                                                                NA\n27                                                                                                NA\n28                                                                                                NA\n29                                                                                                NA\n30                                                                                                NA\n31                                                                                                NA\n32                                                                                                NA\n33                                                                                                NA\n34                                                                                                NA\n35                                                                                                NA\n36                                                                                                NA\n37                                                                                                NA\n38                                                                                                NA\n39                                                                                                NA\n40                                                                                                NA\n41                                                                                                NA\n42                                                                                                NA\n43                                                                                                NA\n44                                                                                                NA\n45                                                                                                NA\n46                                                                                                NA\n47                                                                                                NA\n48                                                                                                NA\n49                                                                                                NA\n50                                                                                                NA\n51                                                                                                NA\n52                                                                                                NA\n53                                                                                                NA\n54                                                                                                NA\n55                                                                                                NA\n56                                                                                                NA\n57                                                                                                NA\n58                                                                                                NA\n59                                                                                                NA\n60                                                                                                NA\n61                                                                                                NA\n62                                                                                                NA\n63                                                                                                NA\n64                                                                                                NA\n65                                                                                                NA\n66                                                                                                NA\n67                                                                                                NA\n68                                                                                                NA\n69                                                                                                NA\n70                                                                                                NA\n71                                                                                                NA\n72                                                                                                NA\n73                                                                                                NA\n74                                                                                                NA\n75                                                                                                NA\n76                                                                                                NA\n77                                                                                                NA\n78                                                                                                NA\n79                                                                                                NA\n80                                                                                                NA\n81                                                                                                NA\n82                                                                                                NA\n83                                                                                                NA\n84                                                                                                NA\n85                                                                                                NA\n86                                                                                                NA\n87                                                                                                NA\n88                                                                                                NA\n89                                                                                                NA\n90                                                                                                NA\n91                                                                                                NA\n92                                                                                                NA\n93                                                                                                NA\n94                                                                                                NA\n95                                                                                                NA\n96                                                                                                NA\n97                                                                                                NA\n98                                                                                                NA\n99                                                                                                NA\n100                                                                                               NA\n    number_of_subjects_with_30_percent_reduction_in_weekly_average_pain_intensity_score_endpoint_percent\n1                                                                                                     NA\n2                                                                                                     NA\n3                                                                                                     NA\n4                                                                                                     NA\n5                                                                                                     NA\n6                                                                                                     NA\n7                                                                                                     NA\n8                                                                                                     NA\n9                                                                                                     NA\n10                                                                                                    NA\n11                                                                                                    NA\n12                                                                                                    NA\n13                                                                                                    NA\n14                                                                                                    NA\n15                                                                                                    NA\n16                                                                                                    NA\n17                                                                                                    NA\n18                                                                                                    NA\n19                                                                                                    NA\n20                                                                                                    NA\n21                                                                                                    NA\n22                                                                                                    NA\n23                                                                                                    NA\n24                                                                                                    NA\n25                                                                                                    NA\n26                                                                                                    NA\n27                                                                                                    NA\n28                                                                                                    NA\n29                                                                                                    NA\n30                                                                                                    NA\n31                                                                                                    NA\n32                                                                                                    NA\n33                                                                                                    NA\n34                                                                                                    NA\n35                                                                                                    NA\n36                                                                                                    NA\n37                                                                                                    NA\n38                                                                                                    NA\n39                                                                                                    NA\n40                                                                                                    NA\n41                                                                                                    NA\n42                                                                                                    NA\n43                                                                                                    NA\n44                                                                                                    NA\n45                                                                                                    NA\n46                                                                                                    NA\n47                                                                                                    NA\n48                                                                                                    NA\n49                                                                                                    NA\n50                                                                                                    NA\n51                                                                                                    NA\n52                                                                                                    NA\n53                                                                                                    NA\n54                                                                                                    NA\n55                                                                                                    NA\n56                                                                                                    NA\n57                                                                                                    NA\n58                                                                                                    NA\n59                                                                                                    NA\n60                                                                                                    NA\n61                                                                                                    NA\n62                                                                                                    NA\n63                                                                                                    NA\n64                                                                                                    NA\n65                                                                                                    NA\n66                                                                                                    NA\n67                                                                                                    NA\n68                                                                                                    NA\n69                                                                                                    NA\n70                                                                                                    NA\n71                                                                                                    NA\n72                                                                                                    NA\n73                                                                                                    NA\n74                                                                                                    NA\n75                                                                                                    NA\n76                                                                                                    NA\n77                                                                                                    NA\n78                                                                                                    NA\n79                                                                                                    NA\n80                                                                                                    NA\n81                                                                                                    NA\n82                                                                                                    NA\n83                                                                                                    NA\n84                                                                                                    NA\n85                                                                                                    NA\n86                                                                                                    NA\n87                                                                                                    NA\n88                                                                                                    NA\n89                                                                                                    NA\n90                                                                                                    NA\n91                                                                                                    NA\n92                                                                                                    NA\n93                                                                                                    NA\n94                                                                                                    NA\n95                                                                                                    NA\n96                                                                                                    NA\n97                                                                                                    NA\n98                                                                                                    NA\n99                                                                                                    NA\n100                                                                                                   NA\n [ reached 'max' / getOption(\"max.print\") -- omitted 351 rows ]\n\n[[8]]\n# A tibble: 451 x 10\n   outcome  study    arm        withdrawal_1_year_… withdrawal_1_year…\n   <chr>    <glue>   <chr>                    <dbl>              <dbl>\n 1 withdra… Arnold … Placebo                     NA                 NA\n 2 withdra… Arnold … Esreboxet…                  NA                 NA\n 3 withdra… Gonzale… Physical …                  NA                 NA\n 4 withdra… Gonzale… Sertralin…                  NA                 NA\n 5 withdra… Hammody… Pregabali…                  NA                 NA\n 6 withdra… Hammody… Amitripty…                  NA                 NA\n 7 withdra… Cardena… Benzotrop…                  NA                 NA\n 8 withdra… Cardena… Amitripty…                  NA                 NA\n 9 withdra… Gould 2… Benzotrop…                  NA                 NA\n10 withdra… Gould 2… Desiprami…                  NA                 NA\n# … with 441 more rows, and 5 more variables:\n#   withdrawal_2_weeks_low_dose_endpoint_percent <dbl>,\n#   withdrawal_2_weeks_low_dose_endpoint_n <dbl>,\n#   withdrawal_3_months_acute_phase_post_intervention_percent <dbl>,\n#   withdrawal_3_months_acute_phase_post_intervention_n <dbl>,\n#   withdrawal_4_weeks_high_dose_endpoint_percent <dbl>\n\n[[9]]\n# A tibble: 451 x 10\n   outcome  study   arm      good_pain_relief_50… good_pain_relief_50…\n   <chr>    <glue>  <chr>                   <dbl>                <dbl>\n 1 pain_sub Arnold… Placebo                    NA                   NA\n 2 pain_sub Arnold… Esrebox…                   NA                   NA\n 3 pain_sub Gonzal… Physica…                   NA                   NA\n 4 pain_sub Gonzal… Sertral…                   NA                   NA\n 5 pain_sub Hammod… Pregaba…                   NA                   NA\n 6 pain_sub Hammod… Amitrip…                   NA                   NA\n 7 pain_sub Carden… Benzotr…                   NA                   NA\n 8 pain_sub Carden… Amitrip…                   NA                   NA\n 9 pain_sub Gould … Benzotr…                   NA                   NA\n10 pain_sub Gould … Desipra…                   NA                   NA\n# … with 441 more rows, and 5 more variables:\n#   number_of_responders_50_percent_improvement_in_brief_pain_inventory_average_pain_bocf_endpoint_percent <dbl>,\n#   number_of_responders_50_percent_improvement_in_brief_pain_inventory_average_pain_bocf_endpoint_n <lgl>,\n#   pain_100_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_endpoint_percent <dbl>,\n#   pain_100_percent_decrease_in_weekly_mean_24_hour_pain_severity_patient_diaries_endpoint_n <lgl>,\n#   pain_50_percent_decrease_from_baseline_in_average_24hr_pain_score_endpoint_percent <dbl>\n\nstudy-level information\nobservations and observation-level information\n\n\n# desired output structure\n\ntar_read(p_obs)\n\n\n# A tibble: 1 x 5\n  outcome    study      arm      obs             obs_info             \n  <chr>      <chr>      <chr>    <chr>           <chr>                \n1 mood, pai… unique st… unique … columns with m… \"information extract…\n\n# pipeline overview\n\ntar_visnetwork(allow = c(w_study_label_obs, starts_with(\"w_obs_\")))\n\n\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n|\n\n/\nLoading required package: dontpanic\n\n-\n\n\\\n\n|\n\n/\n\n-\n\n\\\n\n \n\n{\"x\":{\"nodes\":{\"name\":[\"w_obs_calc\",\"w_obs_investigate\",\"w_obs_long\",\"w_obs_long_filtered\",\"w_obs_scale_counts\",\"w_obs_scale_excluded\",\"w_obs_scale_excluded_next\",\"w_obs_scale_matches\",\"w_obs_scale_snapshot\",\"w_obs_scales\",\"w_obs_scales_viable\",\"w_obs_time\",\"w_obs_viable\",\"w_obs_wide\",\"w_study_label_obs\"],\"type\":[\"stem\",\"stem\",\"pattern\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"stem\",\"pattern\"],\"status\":[\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\",\"uptodate\"],\"seconds\":[0.022,0.011,2.295,0.03,5.626,0.011,0.015,47.276,0.007,0.001,6.815,0.03,0.016,0.029,0.275],\"bytes\":[21912,10394,85723,19424,36770,2212,359,36651,151,20648,20648,17553,13818,17058,193114],\"branches\":[null,null,9,null,null,null,null,null,null,null,null,null,null,null,9],\"id\":[\"w_obs_calc\",\"w_obs_investigate\",\"w_obs_long\",\"w_obs_long_filtered\",\"w_obs_scale_counts\",\"w_obs_scale_excluded\",\"w_obs_scale_excluded_next\",\"w_obs_scale_matches\",\"w_obs_scale_snapshot\",\"w_obs_scales\",\"w_obs_scales_viable\",\"w_obs_time\",\"w_obs_viable\",\"w_obs_wide\",\"w_study_label_obs\"],\"label\":[\"w_obs_calc\",\"w_obs_investigate\",\"w_obs_long\",\"w_obs_long_filtered\",\"w_obs_scale_counts\",\"w_obs_scale_excluded\",\"w_obs_scale_excluded_next\",\"w_obs_scale_matches\",\"w_obs_scale_snapshot\",\"w_obs_scales\",\"w_obs_scales_viable\",\"w_obs_time\",\"w_obs_viable\",\"w_obs_wide\",\"w_study_label_obs\"],\"level\":[9,11,2,3,5,6,7,4,6,7,6,8,10,7,1],\"color\":[\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\",\"#354823\"],\"shape\":[\"dot\",\"dot\",\"square\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"dot\",\"square\"]},\"edges\":{\"from\":[\"w_obs_scales_viable\",\"w_obs_long\",\"w_obs_scales_viable\",\"w_obs_scale_counts\",\"w_obs_time\",\"w_study_label_obs\",\"w_obs_scale_counts\",\"w_obs_scale_matches\",\"w_obs_calc\",\"w_obs_scale_excluded\",\"w_obs_long_filtered\",\"w_obs_scale_counts\",\"w_obs_calc\",\"w_obs_viable\",\"w_obs_wide\"],\"to\":[\"w_obs_scales\",\"w_obs_long_filtered\",\"w_obs_wide\",\"w_obs_scale_snapshot\",\"w_obs_calc\",\"w_obs_long\",\"w_obs_scales_viable\",\"w_obs_scale_counts\",\"w_obs_viable\",\"w_obs_scale_excluded_next\",\"w_obs_scale_matches\",\"w_obs_scale_excluded\",\"w_obs_investigate\",\"w_obs_investigate\",\"w_obs_time\"],\"arrows\":[\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\",\"to\"]},\"nodesToDataframe\":true,\"edgesToDataframe\":true,\"options\":{\"width\":\"100%\",\"height\":\"100%\",\"nodes\":{\"shape\":\"dot\",\"physics\":false},\"manipulation\":{\"enabled\":false},\"edges\":{\"smooth\":{\"type\":\"cubicBezier\",\"forceDirection\":\"horizontal\"}},\"physics\":{\"stabilization\":false},\"layout\":{\"hierarchical\":{\"enabled\":true,\"direction\":\"LR\"}}},\"groups\":null,\"width\":null,\"height\":null,\"idselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"useLabels\":true,\"main\":\"Select by id\"},\"byselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"multiple\":false,\"hideColor\":\"rgba(200,200,200,0.5)\",\"highlight\":false},\"main\":{\"text\":\"\",\"style\":\"font-family:Georgia, Times New Roman, Times, serif;font-weight:bold;font-size:20px;text-align:center;\"},\"submain\":null,\"footer\":null,\"background\":\"rgba(0, 0, 0, 0)\",\"highlight\":{\"enabled\":false,\"hoverNearest\":false,\"degree\":1,\"algorithm\":\"all\",\"hideColor\":\"rgba(200,200,200,0.5)\",\"labelOnly\":true},\"collapse\":{\"enabled\":true,\"fit\":false,\"resetHighlight\":true,\"clusterOptions\":null,\"keepCoord\":true,\"labelSuffix\":\"(cluster)\"},\"legend\":{\"width\":0.2,\"useGroups\":false,\"position\":\"right\",\"ncol\":1,\"stepX\":100,\"stepY\":100,\"zoom\":true,\"nodes\":{\"label\":[\"Up to date\",\"Stem\",\"Pattern\"],\"color\":[\"#354823\",\"#899DA4\",\"#899DA4\"],\"shape\":[\"dot\",\"dot\",\"square\"]},\"nodesToDataframe\":true}},\"evals\":[],\"jsHooks\":[]}\nBefore we identify timepoints and other observation-level variables, we check that the data are in the correct format. The measure_desc column is the orgiinal column header from Covidence prefix for the measure. We’ll extract the observation-level variables (timepoint and scale) from this column.\n\n\ntar_read(w_obs_wide)\n\n\n# A tibble: 1,444 x 15\n   outcome study  arm    covidence_desc  scale  model_type  mean     n\n   <chr>   <glue> <chr>  <chr>           <chr>  <chr>      <dbl> <int>\n 1 mood    rinta… gabap… depression_cen… cente… smd          7.2    22\n 2 mood    rinta… amitr… depression_cen… cente… smd          7.2    22\n 3 mood    rinta… diphe… depression_cen… cente… smd          7.2    22\n 4 mood    graff… amitr… anxiety_state_… state… smd         80.3    11\n 5 mood    graff… amitr… anxiety_state_… state… smd         65.8    11\n 6 mood    graff… amitr… anxiety_state_… state… smd         76.6    11\n 7 mood    graff… amitr… anxiety_state_… state… smd         84.7    11\n 8 mood    graff… amitr… depression_bec… beck_… smd         12.1    11\n 9 mood    graff… amitr… depression_bec… beck_… smd         11.1    11\n10 mood    graff… amitr… anxiety_state_… state… smd         64.8    12\n# … with 1,434 more rows, and 7 more variables: sd <dbl>,\n#   range <chr>, se <dbl>, median <dbl>, ci <chr>, iqr <chr>,\n#   percent <dbl>\n\ntimepoints\nWe are interested in classifying timepoints as post-intervention, short-term follow up, and long-term follow up.\n\n\n# get counts for timepoints, particularly interested in checking there are no unmatched timepoints\ntar_read(w_obs_time) %>% \n  count(timepoint)\n\n\n# A tibble: 5 x 2\n  timepoint     n\n  <chr>     <int>\n1 baseline    501\n2 follow_up     6\n3 mid_int     128\n4 post_int    803\n5 unmatched     6\n\nscales\n\n\n\n\n\n\n",
      "last_modified": "2021-07-19T20:37:24+01:00"
    }
  ],
  "collections": []
}
